like cancer‚ transplant rejection and inflammation. B. Abgenix Ways To Generate Revenue: Abgenix generated revenues in two different ways: 1- It licensed XenoMouse technology to numerous corporate collaborators including leading pharmaceutical companies. A collaborator paid an upfront fee‚ agreed to payments as the drug development program reached certain milestones and a royalty on sales should the drug be commercialized. 2- The second way Abgenix hoped to generate revenues was
Premium Clinical trial Food and Drug Administration Drug development
Biocon Ltd. Building a Biotech Powerhouse Case analysis -Rajdeep Desai Introduction: Established in 1978‚ Biocon Limited is Asia’s premier biotechnology company and India’s largest biotechnology company by revenue. It is the only Asian company among the top 25 in global biopharma. Biocon is called as Poster child of Biotech in India. The Group‚ promoted by Ms. Kiran Mazumdar Shaw‚ is a fully-integrated‚ innovation-driven healthcare enterprise with strategic focus on biopharmaceuticals and
Premium Clinical trial Biotechnology Pharmaceutical industry
Clinical trials in INDIA- Legal issues By: Vallinadh Karamcheti Abstract: Clinical trials are conducted to ensure the safety and efficacy of the drug. They are conducted on the human subjects. Hence the clinical trials are liable to many legal aspects. Clinical trials are conducted in four phases. (Phase I‚ Phase II‚ Phase III‚ & Phase IV). All the phases of the clinical trials should comply with several legal aspects‚ as life of a person may be at risk if anything goes wrong with the clinical
Premium Clinical trial Pharmacology Pharmaceutical industry
Antibacterial activity of allopathic medicine versus phytomedicine against Enterococcus faecalis: An in-vitro study. Abstract Background: A successful endodontic treatment depends on appropriate instrumentation‚ irrigation‚ decontamination and obturation. Decontamination of root canal plays a crucial role in the success of endodontic treatment. Therefore‚ a suitable medicament is essential which can effectively eliminate bacterial contamination. Aim and objectives: To investigate and compare the
Premium Pharmacology Bacteria Antibiotic resistance
A potential problem for Pfizer Lipitor brand and their R&D activities‚ as well as their business in general‚ is the fact that Lipitor will soon lose its patent protection. The problem is that they do not have any suitable replacements for the revenue that will soon be lost due to the emergence of generic drugs following a branded drugs loss of patent protection. Their main source of revenue‚ Lipitor (sales of $10 billion last year)‚ will lose its patent protection in 2010. 4 Alternative/Suggested
Premium Marketing Competition Brand
successful performance of Dr. Reddy’s can be described in 2 parts viz Pre FY 2000 Era and Post 2000 Era. Pre 2000 Era • Dr. Reddy’s formed a chemical based company named Dr. Reddy’s Laboratories to manufacture and supply active pharmaceutical ingredients to domestic drug companies by identifying a potential opportunity to do business in the chemical sector. This gave Dr. Reddy’s opportunities to popularize it s brand by formulating its own drugs to sustain in the highly competitive
Premium Generic drug Pharmaceutical industry Drug development
AIU Online Unit 4 IP December 4‚ 2011 Abstract A pharmaceutical company has rights to a drug paten but it takes a lot to get that patent. Until that can happen‚ anyone can make a similar drug and get it approved to sell on the market. Making sure the company acts in a proper way is important. When companies
Premium Generic drug Pharmaceutical industry Food and Drug Administration
2 Operations Strategy in a Global Environment PowerPoint presentation to accompany Heizer and Render Operations Management‚ 10e Principles of Operations Management‚ 8e PowerPoint slides by Jeff Heyl © 2011 Pearson Education‚ Inc. publishing as Prentice Hall 2-1 Developing Missions and Strategies Mission statements tell an organization where it is going The Strategy tells the organization how to get there © 2011 Pearson Education‚ Inc. publishing as Prentice Hall 2-2
Premium Product management Generic drug Pearson PLC
1) What are the pros and cons of Abgenix’s collaborating with a partner on ABX-EGF? Before a new drug can be released to the market‚ it has to undergo a regulatory process. To complete the process‚ first the drug company (the sponsor in the process) has to submit information to prove that the drug is safe and effective. Pre-clinical data first has to be submitted before clinical trials can be conducted. After demonstrating the safety and efficacy of the drug through successful clinical trials
Premium Drug development Pharmaceutical industry Firm
infant industry argument is an economic reason for protectionism. The crux of the argument is that nascent industries often do not have the economies of scale that their older competitors from other countries may have‚ and thus need to be protected until they can attain similar economies of scale. It was first used by Alexander Hamilton in 1790 and later by Friedrich List‚ in 1841‚ to support protection for German manufacturing against British industry.[1] Protectionism allows an industry to develop
Premium Industry International trade Capitalism